Science and Engineering Ethics 11 (1):81-92 (2005)
This paper offers a few elements of an answer to the question to what extent drug patents can be morally justified. Justifications based on natural rights, distributive justice and utilitarian arguments are discussed and criticized. The author recognizes the potential of the patents to benefit society but argues that the system is currently evolving in the wrong direction, particularly in the field of drugs. More than a third of the world’s population has no access to essential drugs. The working of the patent system is an important determinant of access to drugs. This paper argues that drug patents are not easily justified and that the ‘architecture’ of the patent system should be rethought in view of its mission of benefiting society.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
References found in this work BETA
Some Questions About the Moral Responsibilities of Drug Companies in Developing Countries.Dan W. Brock - 2001 - Developing World Bioethics 1 (1):33-37.
Citations of this work BETA
No citations found.
Similar books and articles
It's About Scientific Secrecy, Dummy: A Better Equilibrium Among Genomics Patenting, Scientific Research and Health Care. [REVIEW]Miriam Bentwich - 2012 - Science and Engineering Ethics 18 (2):263-284.
Surgical Patents and Patients — the Ethical Dilemmas.Tadeusz Tołłoczko - 2005 - Science and Engineering Ethics 11 (1):61-69.
Peer-Review and Patents: Why the Goose That Lays the Golden Egg is a Red Herring.Sivaramjani Thambisetty & Kartik Kumaramangalam - unknown
Patents and Access to Drugs in Developing Countries: An Ethical Analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
America's Unjust Drug War.Michael Huemer - 2004 - In Bill Masters (ed.), The New Prohibition. Accurate Press.
Added to index2009-01-28
Total downloads29 ( #175,046 of 2,159,120 )
Recent downloads (6 months)2 ( #192,839 of 2,159,120 )
How can I increase my downloads?